A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/21/2002	US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002	US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002	US20020173528 Agonists specific for the peripheral cannabinoid receptor
11/21/2002	US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002	US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002	US20020173518 Anticoagulant in mammls
11/21/2002	US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002	US20020173506 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173499 Estrogen replacement therapy
11/21/2002	US20020173464 Modulation of pericyte proliferation
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020173449 O-superfamily conotoxin peptides
11/21/2002	US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002	US20020172958 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
11/21/2002	US20020172721 Vitamin formulation for cardiovascular health
11/21/2002	US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002	US20020172663 Localized myocardial injection method for treating ischemic myocardium
11/21/2002	US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
11/21/2002	DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002	DE10123952A1 New naphtho-1,2-thiazine compounds, useful as neuroprotectants for treating e.g. epilepsy or Alzheimer's disease, are allosteric modulators of AMPA receptors
11/21/2002	DE10122715A1 Verwendung von Rutinen und Aescinen zur Behandlung aurikulärer Durchblutungsstörungen Use of rutins and Aescinen for treating auricular circulatory disorders
11/21/2002	DE10122714A1 Combination of a rutin and aescin for treating ocular disorders associated with altered blood circulation, e.g. glaucoma or edema
11/21/2002	CA2451116A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	CA2449292A1 Dipeptide derivatives
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002	CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	CA2447005A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	CA2446839A1 Method of modulating the activity of calcium channels in cardiac cells and reagents therefor
11/21/2002	CA2446797A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002	CA2446763A1 Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	CA2446720A1 High density lipoprotein-reactive peptides
11/21/2002	CA2446605A1 Novel processes for the preparation of adenosine compounds and intermediates thereto
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	CA2443191A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/20/2002	WO2001091776A1 Hypotensive and hypertensive properties of renomedullar extracts
11/20/2002	EP1258484A1 Novel isoxazole and thiazole compounds and use thereof as drugs
11/20/2002	EP1258474A2 Alkylamide compounds
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1258250A1 Nerve protective drugs
11/20/2002	EP1257819A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels
11/20/2002	EP1257653A2 Phosphodiesterase type 7b
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002	EP1257582A2 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257573A2 New transcription factor carp-2
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002	EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002	EP1257550A1 Platelet adp receptor inhibitors
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002	EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002	EP1257530A1 Aminosulfonylbiphenyl derivatives
11/20/2002	EP1257528A1 Aminoalcohol derivatives
11/20/2002	EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002	EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002	EP1257297A2 Compositions and methods for treatment of angiogenesis in pathological lesions
11/20/2002	EP1257295A2 Factor vii or viia-like molecules
11/20/2002	EP1257280A1 Drospirenone for hormone replacement therapy
11/20/2002	EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
11/20/2002	EP1257272A1 Thiazolium compounds and treatments of disorders associated with protein aging
11/20/2002	EP1257264A1 Estrogen receptor modulators
11/20/2002	EP1257263A2 Microcompetiton and human disease
11/20/2002	EP1165472A4 Methods for the preparation of biphenyl isoxazole sulfonamides
11/20/2002	EP1162987B1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
11/20/2002	EP1156759A4 Biodegradable polymeriprotein based coils for intralumenal implants
11/20/2002	EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
11/20/2002	EP1140190B1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
11/20/2002	EP0984952B1 A new salt
11/20/2002	EP0935469B1 Use of growth hormone
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0845992B1 Use of relaxin for promoting angiogenesis
11/20/2002	EP0833828B1 Rapamycin derivatives
11/20/2002	EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002	EP0593603B1 Bicyclic fibrinogen antagonists
11/20/2002	CN1380885A Alginate having low molecular weight, method of manufacturing it and its use
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380881A Methods for crystallization of N-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanine N-carboxyanhydride
11/20/2002	CN1380288A Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application
11/20/2002	CN1380279A (4-alkynyl), aromatic keto-acid compound, synthesis method and its application

1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 1595